Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,340,326
-
Share change
-
+1,298,654
-
Total reported value
-
$80,563,689
-
Price per share
-
$2.28
-
Number of holders
-
91
-
Value change
-
+$1,950,129
-
Number of buys
-
39
-
Number of sells
-
48
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q1 2020
As of 31 Mar 2020,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,340,326 shares.
The largest 10 holders included
BVF INC/IL, Aquilo Capital Management, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Corriente Advisors, LLC, Samsara BioCapital, LLC, Tekla Capital Management LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and Woodline Partners LP.
This page lists
91
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.